New EMCDDA report highlights greater diversity of cannabis products, increasing potency and the need for close monitoring of health effects

Cannabis products have become increasingly diverse in Europe and close monitoring of their potency and potential health effects is essential. These are among the conclusions of a new report published today by the EU drugs agency (EMCDDA) ahead of International day against drug abuse and illicit trafficking (26 June) (1). 25.06.2019